Amarantus Amarantus Reacquires Neurology Diagnostic Assets from Avant Amarantus has reacquired LymPro Test, MSPrecise, and NuroPro and said that it plans to assign the assets to a new subsidiary. Avant Completes Acquisitions of Amarantus, Theranostics Health The deals bring together Avant's ovarian cancer diagnostic, Amarantus' multiple sclerosis and Alzheimer's disease assays, and Theranostics' CLIA lab. Achieving Dx Ambitions Key to Avant-Amarantus-Theranostics Merger Premium The deal brings together three firms that have struggled to ramp their test businesses in hopes that the combined outfit will be better positioned to succeed. Avant, Amarantus Diagnostics Add Theranostics Health to Planned Merger Avant and Amarantus, which agreed to merge in January, have now signed a deal to acquire Theranostics Health and its CLIA-certified laboratory. Amarantus Inks Deal to Merge Dx Unit with Avant Diagnostics When the merger is complete, Amarantus will own 80 million shares of Avant, representing about 45 percent of the combined company. Oct 1, 2015 Amarantus Bio Moves Into Orphan Disease Theranostics, Raises $5.5M Apr 27, 2015 Amarantus Bio Raises $5M Feb 18, 2015 Amarantus Inks Alzheimer's Biomarker Test Deal with Anavex Jan 15, 2015 Amarantus Options Blood-based Alzheimer's Biomarkers from Georgetown Jan 13, 2015 Amarantus Acquires DioGenix for up to $10.9M Breaking News New Approach Identifies Candidate Causal Variants for Neuropsychiatric, Neurodevelopmental Conditions People in the News: Baylor's Thomas Caskey Dies; New Appointments at UK Biobank, CS Genetics, More In Brief This Week: Pathogenomix, Uniogen, Genetic Technologies, DnaNudge, Gravity Diagnostics, More New Products Posted to GenomeWeb: Biodesix, Curio Genomics, Akoya Biosciences, More NIH Earmarks $170M for All of Us Program's Personalized Nutrition Study Taiwanese Firm's IP Asserted in Suit Against Pacific Biosciences Found Partially Unpatentable The Scan Omicron's Sewage Path The New York Times writes that testing sewage is helping public health officials track Omicron. IBM Sells Part of Watson Health The Wall Street Journal reports IBM is selling part of its Watson Health business to an investment firm. Identifying the Right Whales The Boston Globe writes that genetic testing has helped identify North American right whales and find that weaning can take place earlier than thought. Science Papers on Approach to Quickly Sort Single Cells, Alternative Splicing in Cancer In Science this week: high-speed sorting of single cells using fluorescence imaging, and more.